Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

6.39
Delayed Data
As of 4:00pm ET
 +0.08 / +1.27%
Today’s Change
3.68
Today|||52-Week Range
18.59
-17.44%
Year-to-Date
No recent news for Nivalis Therapeutics Inc.

Today’s Trading

Previous close6.31
Today’s open6.36
Day’s range6.36 - 6.60
Volume27,097
Average volume (3 months)44,290
Market cap$97.8M
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)-156.17%
Earnings growth (this year)+5.76%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.03-1.92%
SBPHSpring Bank Pharmace...-0.69-5.42%
OCXOncoCyte Corp-0.03-0.78%
ORMPOramed Pharmaceutica...-0.14-1.90%
Data as of 4:00pm ET, 08/31/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$0.00
Annual profit (last year)-$22.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Search for Jobs